Literature DB >> 11314748

Cabergoline-induced CSF rhinorrhea in patients with macroprolactinoma. Report of three cases.

P Cappabianca1, S Lodrini, G Felisati, C Peca, R Cozzi, A Di Sarno, L M Cavallo, S Giombini, A Colao.   

Abstract

induces the macroprolactinoma shrinkage. Endoscopic transsphenoidal surgery offers a safe, minimally invasive and efficient management of this complication, which allows to regularly perform the following steps of the therapeutical strategy against the prolactinoma.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11314748     DOI： 10.1007/BF03343840

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN： 0391-4097            Impact factor:   4.256


  29 in total

1.  Endoscopic endonasal transsphenoidal approach: an additional reason in support of surgery in the management of pituitary lesions.

Authors:  P Cappabianca; A Alfieri; A Colao; D Ferone; G Lombardi; E de Divitiis
Journal:  Skull Base Surg       Date:  1999

2.  Endoscopic endonasal transsphenoidal approach to the sella: towards functional endoscopic pituitary surgery (FEPS).

Authors:  P Cappabianca; A Alfieri; E de Divitiis
Journal:  Minim Invasive Neurosurg       Date:  1998-06

3.  Cerebrospinal fluid rhinorrhea in patients with untreated pituitary adenoma: report of two cases.

Authors:  W G Obana; J E Hodes; P R Weinstein; C B Wilson
Journal:  Surg Neurol       Date:  1990-05

4.  Rhinorrhea following dopamine agonist therapy of invasive macroprolactinoma.

Authors:  G Hildebrandt; J Zierski; P Christophis; A Laun; H Schatz; I Lancranjan; N Klug
Journal:  Acta Neurochir (Wien)       Date:  1989       Impact factor: 2.216

5.  Treatment of macroprolactinoma with cabergoline: a study of 85 patients.

Authors:  C I Ferrari; R Abs; J S Bevan; G Brabant; E Ciccarelli; T Motta; M Mucci; M Muratori; L Musatti; G Verbessem; M F Scanlon
Journal:  Clin Endocrinol (Oxf)       Date:  1997-04       Impact factor: 3.478

6.  Transnasal ethmoidectomy under endoscopical control.

Authors:  M E Wigand
Journal:  Rhinology       Date:  1981-03       Impact factor: 3.681

7.  Prolactinomas resistant to standard dopamine agonists respond to chronic cabergoline treatment.

Authors:  A Colao; A Di Sarno; F Sarnacchiaro; D Ferone; G Di Renzo; B Merola; L Annunziato; G Lombardi
Journal:  J Clin Endocrinol Metab       Date:  1997-03       Impact factor: 5.958

8.  Long-term treatment with cabergoline, a new long-lasting ergoline derivate, in idiopathic or tumorous hyperprolactinaemia and outcome of drug-induced pregnancy.

Authors:  E Ciccarelli; S Grottoli; P Razzore; D Gaia; A Bertagna; S Cirillo; T Cammarota; M Camanni; F Camanni
Journal:  J Endocrinol Invest       Date:  1997-10       Impact factor: 4.256

9.  Long-term and low-dose treatment with cabergoline induces macroprolactinoma shrinkage.

Authors:  A Colao; A Di Sarno; M L Landi; S Cirillo; F Sarnacchiaro; G Facciolli; R Pivonello; M Cataldi; B Merola; L Annunziato; G Lombardi
Journal:  J Clin Endocrinol Metab       Date:  1997-11       Impact factor: 5.958

10.  A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea. Cabergoline Comparative Study Group.

Authors:  J Webster; G Piscitelli; A Polli; C I Ferrari; I Ismail; M F Scanlon
Journal:  N Engl J Med       Date:  1994-10-06       Impact factor: 91.245
View more
  8 in total

1.  Cerebrospinal fluid leakage as complication of treatment with cabergoline for macroprolactinomas.

Authors:  R T Netea-Maier; E J van Lindert; H Timmers; E L Schakenraad; J A Grotenhuis; A R Hermus
Journal:  J Endocrinol Invest       Date:  2006-12       Impact factor: 4.256

Review 2.  Medically induced CSF rhinorrhea following treatment of macroprolactinoma: case series and literature review.

Authors:  Tomáš Česák; Pavel Poczos; Jaroslav Adamkov; Jiří Náhlovský; Petra Kašparová; Filip Gabalec; Petr Čelakovský; Ondrej Choutka
Journal:  Pituitary       Date:  2018-12       Impact factor: 4.107

3.  Transnasal trans-sphenoidal endoscopic repair of CSF leak secondary to invasive pituitary tumours using a nasoseptal flap.

Authors:  B Thakur; A R Jesurasa; R Ross; T A Carroll; S Mirza; S Sinha
Journal:  Pituitary       Date:  2011-06       Impact factor: 4.107

Review 4.  Medical therapy of pituitary adenomas: effects on tumor shrinkage.

Authors:  Annamaria Colao; Rosario Pivonello; Carolina Di Somma; Silvia Savastano; Ludovica F S Grasso; Gaetano Lombardi
Journal:  Rev Endocr Metab Disord       Date:  2009-06       Impact factor: 6.514

5.  Management of macroprolactinomas.

Authors:  Amit Tirosh; Ilan Shimon
Journal:  Clin Diabetes Endocrinol       Date:  2015-07-20

6.  Cabergoline-Induced Pneumocephalus Following Treatment for Giant Invasive Macroprolactinoma Presenting With Spontaneous Cerebrospinal Fluid Rhinorrhea.

Authors:  Souha S Elabd; Maswood M Ahmad; Sameer Q Qetab; Mussa Hussain Almalki
Journal:  Clin Med Insights Endocrinol Diabetes       Date:  2018-02-13

7.  Spontaneous Cerebrospinal Fluid Rhinorrhea from a Prolactin-Secreting Pituitary Macroadenoma.

Authors:  Aneek Patel; Yair M Gozal; Hussam Abou-Al-Shaar; Philipp Taussky; William Couldwell
Journal:  Cureus       Date:  2021-02-03

8.  Giant Prolactinoma Presenting With Facial Nerve Palsy and Hemiparesis.

Authors:  Aleksandra Sliwinska; Fatima Jalil; Lori De La Portilla; Michael Baldwin; Joseph Lorenzo; Ketan R Bulsara; Faryal S Mirza
Journal:  J Endocr Soc       Date:  2021-04-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.